Skip to content

EBIT at other companies

Rogers Corporation logo
Rogers CorporationROG
$10.7M+3,667%
Vera Therapeutics logo
Vera TherapeuticsVERA
-$125.13M-119%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$38.89M+48.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$169M-18.2%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$110.03M-3.2%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$29.27M+121%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's EBIT?
Aurinia Pharmaceuticals (AUPH) reported EBIT of $41.42M in Q1 2026.
How has Aurinia Pharmaceuticals's EBIT changed year-over-year?
Aurinia Pharmaceuticals's EBIT increased by 89.6% year-over-year, from $21.85M to $41.42M.
What is the long-term trend for Aurinia Pharmaceuticals's EBIT?
Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's EBIT has grown at a -12.7% compound annual growth rate (CAGR), from -$180.74M to $104.91M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.